Allergy/Imm

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Mandapathil M et al. - CD39 surface marker can be successfully used for routine isolation of functionally-active human Treg from the peripheral blood of healthy donors or patients with cancer for studies of their role in health and disease.

Today in Hematology/Oncology...keeping you current

The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer
Cancer Treatment Reviews, 12/04/09

IL-13 from Th2-type cells suppresses induction of antigen-specific Th1 immunity in a T-cell lymphoma
International Immunology, 12/03/09

Prioritization of cancer antigens: keeping the target in sight
Expert Review of Vaccines, 12/02/09